Cardiff Oncology Inc (CRDF)
3.63
-0.11
(-2.94%)
USD |
NASDAQ |
May 17, 16:00
3.64
+0.01
(+0.28%)
After-Hours: 20:00
Cardiff Oncology Enterprise Value: 95.16M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 95.16M |
| May 16, 2024 | 100.08M |
| May 15, 2024 | 92.48M |
| May 14, 2024 | 92.93M |
| May 13, 2024 | 88.45M |
| May 10, 2024 | 84.43M |
| May 09, 2024 | 83.98M |
| May 08, 2024 | 75.93M |
| May 07, 2024 | 80.85M |
| May 06, 2024 | 87.56M |
| May 03, 2024 | 90.24M |
| May 02, 2024 | 133.18M |
| May 01, 2024 | 122.00M |
| April 30, 2024 | 127.81M |
| April 29, 2024 | 132.28M |
| April 26, 2024 | 114.84M |
| April 25, 2024 | 111.26M |
| April 24, 2024 | 119.70M |
| April 23, 2024 | 119.26M |
| April 22, 2024 | 127.75M |
| April 19, 2024 | 127.30M |
| April 18, 2024 | 128.20M |
| April 17, 2024 | 134.01M |
| April 16, 2024 | 138.03M |
| April 15, 2024 | 168.88M |
| Date | Value |
|---|---|
| April 12, 2024 | 183.64M |
| April 11, 2024 | 186.32M |
| April 10, 2024 | 196.15M |
| April 09, 2024 | 185.87M |
| April 08, 2024 | 195.71M |
| April 05, 2024 | 193.92M |
| April 04, 2024 | 186.32M |
| April 03, 2024 | 171.12M |
| April 02, 2024 | 172.91M |
| April 01, 2024 | 189.00M |
| March 31, 2024 | 171.56M |
| March 28, 2024 | 163.75M |
| March 27, 2024 | 182.07M |
| March 26, 2024 | 165.99M |
| March 25, 2024 | 189.22M |
| March 22, 2024 | 186.54M |
| March 21, 2024 | 154.82M |
| March 20, 2024 | 146.78M |
| March 19, 2024 | 142.76M |
| March 18, 2024 | 156.16M |
| March 15, 2024 | 149.90M |
| March 14, 2024 | 166.43M |
| March 13, 2024 | 166.43M |
| March 12, 2024 | 125.33M |
| March 11, 2024 | 105.67M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-78.69M
Minimum
May 11 2022
836.77M
Maximum
Nov 30 2020
68.43M
Average
1.988M
Median
Enterprise Value Benchmarks
| BioVie Inc | 9.577M |
| Perspective Therapeutics Inc | 817.27M |
| Biolase Inc | 15.13M |
| Tenon Medical Inc | 1.926M |
| Adial Pharmaceuticals Inc | 3.458M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.01M |
| Revenue (Quarterly) | 0.205M |
| Total Expenses (Quarterly) | 11.14M |
| EPS Diluted (Quarterly) | -0.22 |
| Profit Margin (Quarterly) | -4.88K% |
| Earnings Yield | -24.79% |
| Normalized Earnings Yield | -24.79 |